Calithera Biosciences, Inc. (CALA) Social Stream



Calithera Biosciences, Inc. (CALA): $2.78

-0.11 (-3.81%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CALA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 395

in industry

CALITHERA BIOSCIENCES INC (CALA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CALITHERA BIOSCIENCES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 4 $1.5 $1 $1.25 $2.89 -56.75%
2022-01-20 3 $3 $1.5 $2.25 $2.89 -22.15%
2022-02-09 4 $4 $1.5 $2.833 $2.89 -1.97%
2022-04-01 4 $3 $1.5 $2.5 $2.89 -13.49%
2022-05-10 4 $3 $1.5 $2.166 $2.89 -25.05%
2022-05-11 4 $2 $1.5 $1.666 $2.89 -42.35%
2022-08-16 4 $30 $18 $26 $2.89 799.65%
2022-08-18 4 $30 $17 $21.666 $2.89 649.69%
2022-08-29 4 $30 $8 $18.25 $2.89 531.49%

CALA reports an average of 2,987.38% for its upside potential over the past 42 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-12 4 1.5 1.0 1.250 0.986 26.77%
2022-02-09 4 4.0 1.5 2.833 0.511 454.4%
2022-04-01 4 3.0 1.5 2.500 0.367 581.2%
2022-05-11 4 2.0 1.5 1.666 0.160 941.25%
2022-08-29 4 30.0 8.0 18.250 3.830 376.5%

CALA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 4 0 0 0 0 4

The Trend in the Broker Recommendations


Over the past 29 months, CALA's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, CALITHERA BIOSCIENCES INC's upside potential (average analyst target price relative to current price) is higher than 489.37% of them.
  • In terms of how CALITHERA BIOSCIENCES INC fares relative to all US stocks, note that its average analyst price target is higher than 164.57% of that group.
  • To contextualize these metrics, consider that out of Healthcare stocks, CALITHERA BIOSCIENCES INC's number of analysts covering the stock is greater than 263.12% of them.
  • CALA has a lower variance in analysts' estimates than -461.3% of Pharmaceutical Products stocks.

Stocks similar to CALITHERA BIOSCIENCES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BYSI, BWV, and BTX.

What is the outlook for CALA? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6499 seconds.